< Back to latest news & events

News

Applications to opt-out pass the 100,000 mark

May 2023

There is now less than three weeks to go until the UPC opens its doors on 1 June 2023.  On the 9th of May the UPC has passed the 100,000 milestone of applications to opt-out.  During the first week of May the numbers of applications being filed increased significantly and we are expecting a further sharp increase as we move towards the last day of the sunrise phase on 31 May 2023.

 

This sunrise phase has presented us with not entirely unexpected challenges. From 4 to 7 April, the UPC took their own Case Management System (CMS) as well as the API functionalities offline without prior notice for maintenance reasons. From 3 to 5 May, we experienced similar problems, this time without any information on the part of the UPC. Additionally, the system seems to have difficulties coping with the rising number of opt-out requests filed, resulting in delays on the part of the UPC’s systems to process these requests.   Unfortunately, the UPC’s system problems persist.

 

If you have not already done so, we strongly advise clients to provide and verify their instructions to us via our dedicated UPC Opt-Out Client Portal.  However, taking into account the above situation, it is our responsibility to advise you that in the light of recent problems with the UPC system, your opt-out requests may not be filed and registered by 31 May 2023.  Given the time constraints, we advise focusing on instructing the opt-out for key granted European patents at first.

 

It is also important to remember that  you can still validly file opt-out requests after 1 June 2023 as long as no litigation action is pending before the UPC for the European patent/application  in question.

 

If you have any questions on the above, please do not hesitate to contact us via upclitigations@hgf.com or contact your usual HGF representative.

Latest updates

Event - 11th November 2025

OIS Investor Forum - Jeffries

HGF is proud to be sponsoring the OIS Investor Forum on 18th November. One of the premier gatherings for leaders, innovators, and investors across the healthcare industry. The forum covers …

Event details

From Stripes to Supermarkets: The Court of Appeal Reaffirms the Need for Precision in Trade Mark Law

On 23 October 2025, Lord Justice Arnold delivered two landmark Court of Appeal decisions addressing trade mark registrability: Thom Browne Inc & Anor v adidas AG [2025] EWCA Civ 1340 …

Read article

Protecting Digital Health innovation in the AI revolution

As artificial intelligence (AI) continues to transform healthcare, from diagnostic imaging and drug discovery to wearable devices and clinical decision support, questions around how to protect these advancements have become …

Read article

Doubling Up on Added Matter at the UPC

Following the UPC Court of Appeal (CoA) decision in Abbott v Sibio (APL_39664/2024, 14 February 2025) we now have a second CoA decision on added matter in expert Klein v …

Read article
Event - 4th November 2025

HGF are Silver Sponsors of LSPN Europe 2025

HGF is proud to be a Silver Sponsor of LSPN Europe 2025, a leading forum dedicated to helping life sciences innovators protect and leverage their intellectual property across the entire …

Event details
Event - 30th - 31st October 2025

RAPS European Digital Technologies and Software conference

HGF is proud to be attending the RAPS European Digital Technologies and Software conference in The Netherlands on 30th-31st October. HGF Partner and Patent Attorney Janine Swarbrick and Patent Director …

Event details

Protect It Before You Promote It: IP Advice for MedTech Innovators

Developed a new medical product? Check. Got tickets to an exciting MedTech conference to show off your new product? Check. Intellectual property? Pardon? In the excitement of bringing a new …

Read article

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Read article